References
- Ahmed M, Advani S, Moreira A, et al. Multisystem inflammatory syndrome in children: a systematic review. EclinicalMedicine. 2020;26:100527.
- Kamrath C, Monkemoller K, Biester T, Rohrer TR, et al. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. JAMA. 2020;324(8):801–804.
- Merrill JT, Erkan D, Winakur J, et al. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16(10):581–589.
- World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. 2020. Available from: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Last Accessed on 25 July 2021
- Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607–1608.
- Royal College of Paediatrics and Child Health. Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19. 2020 Available from: https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance. Last Accessed on July 25 2021.
- Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome (MIS). 2020. Available from: https://www.cdc.gov/mis/index.html. Last Accessed on 25 July 2021.
- Nielsen-Saines K, LE, Olivera AM, Martin-Blais R, et al. Case report: insulin-dependent diabetes mellitus and diabetic Keto-Acidosis in a child with COVID-19. Front Pediatr. 2021;9:628810.
- Unsworth R, Wallace S, Oliver NS, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care. 2020;43(11):e170–e1.
- Tittel SR, Rosenbauer J, Kamrath C, DPV Initiative, et al. Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care. 2020;43(11):e172–e3.
- Rubino F, Amiel SA, Zimmet P, et al. New-onset diabetes in covid-19. N Engl J Med. 2020;383(8):789–790.
- Salmi H, Heinonen S, Hastbacka J, et al. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic. Arch Dis Child. 2022;107(2):180–185.
- Yang JK, Lin SS, Ji XJ, et al. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47(3):193–199.
- Abdi A, Jalilian M, Sarbarzeh PA, et al. Diabetes and COVID-19: a systematic review on the current evidences. Diabetes Res Clin Pract. 2020;166:108347.
- Inamdar S, Benias PC, Liu Y, Northwell COVID-19 Research Consortium, et al. Prevalence, risk factors, and outcomes of hospitalized patients with coronavirus disease 2019 presenting as acute pancreatitis. Gastroenterology. 2020;159(6):2226–2228 e2.
- Stevens JP, Brownell JN, Freeman AJ, et al. COVID-19-associated multisystem inflammatory syndrome in children presenting as acute pancreatitis. J Pediatr Gastroenterol Nutr. 2020;71(5):669–671.
- Diorio C, McNerney KO, Lambert M, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020;4(23):6051–6063.
- Khan IA, Karmakar S, Chakraborty U, et al. Purpura fulminans as the presenting manifestation of COVID-19. Postgrad Med J. 2021;97(1149):473.